In This Article:
Vitura Health (ASX:VIT) Full Year 2024 Results
Key Financial Results
-
Revenue: AU$123.9m (up 5.6% from FY 2023).
-
Net income: AU$3.51m (down 75% from FY 2023).
-
Profit margin: 2.8% (down from 12% in FY 2023). The decrease in margin was driven by higher expenses.
-
EPS: AU$0.006 (down from AU$0.025 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Vitura Health shares are up 15% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 6 warning signs for Vitura Health you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.